Postprandial hyperglycemia alters inflammatory and hemostatic parameters

Diabetes and Metabolism

Volumn 32, Issue HS2, 2006, Pages

  Wautier, J L ^a,b,c   Boulanger, E ^a   Wautier, M P ^b  

^a INSTITUT NATIONAL DE LA TRANSFUSION SANGUINE   (France)

^b INSERM   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Adhesion molecules; Cytokines; Fibrinogen; Hyperglycemia; Oxidant stress; Postprandial state

Indexed keywords

C REACTIVE PROTEIN; CYTOKINE; FIBRINOGEN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; NITRIC OXIDE; PLASMINOGEN ACTIVATOR INHIBITOR; THROMBOPLASTIN; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1; ADVANCED GLYCATION END PRODUCT; ARGININE; LYSINE;

ARTICLE; CELL FUNCTION; CYTOKINE RELEASE; ENDOTHELIUM CELL; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HALF LIFE TIME; HUMAN; HYPERGLYCEMIA; OXIDATIVE STRESS; HEMOSTASIS; INFLAMMATION; METABOLISM; PATHOPHYSIOLOGY; POSTPRANDIAL STATE;

ARGININE; GLYCOSYLATION END PRODUCTS, ADVANCED; HEMOSTASIS; HUMANS; HYPERGLYCEMIA; INFLAMMATION; LYSINE; OXIDATIVE STRESS; POSTPRANDIAL PERIOD;

EID: 34248355155     PISSN: 12623636     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1262-3636(06)70483-9     Document Type: Article

References (14)

1. Wautier JL, Guillausseau PJ. Advanced glycation end products, their receptors and diabetic angiopathy. Diabetes Metab 2001;27:535-42.
2. Brownlee M. The pathobiology of diabetic complications: a unifying mechanism. Diabetes 2005;54:1615-25.
3. Nishikawa T, Edelstein D, Du XL, et al. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 2000;404:787-90.
4. Wautier JL, Schmidt AM. Protein glycation: a firm link to endothelial cell dysfunction. Circ Res 2004;95:233-8.
5. Wautier JL, Wautier MP, Schmidt AM, et al. Advanced glycation end products (AGEs) on the surface of diabetic erythrocytes bind to the vessel wall via a specific receptor inducing oxidant stress in the vasculature: a link between surface-associated AGEs and diabetic complications. Proc Natl Acad Sci USA 1994;91:7742-6.
6. Boulanger E, Wautier MP, Wautier JL, et al. AGEs bind to mesothelial cells via RAGE and stimulate VCAM-1 expression. Kidney Int 2002;61:148-56.
7. Boulanger E, Wautier MP, Gane P, Mariette C, Devuyst O, Wautier JL.The triggering of human peritoneal mesothelial cell apoptosis and oncosis by glucose and glycoxydation products. Nephrol Dial Transplant 2004;19:2208-16.
8. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001;414:813-20.
9. Singleton JR, Smith AG, Russell JW, Feldman EL. Microvascular complications of impaired glucose tolerance. Diabetes 2003;52:2867-73.
10. Vlassara H, Cai W, Crandall J, et al. Inflammatory mediators are induced by dietary glycotoxins, a major risk factor for diabetic angiopathy. Proc Natl Acad Sci USA 2002;99:15596-601.
11. Esposito K, Nappo F, Marfella R, et al.Giugliano G, Giugliano F, Ciotola M, Quagliaro L, Ceriello A, Giugliano D. Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress. Circulation 2002;106:2067-72.
12. Piconi L, Quagliaro L, Da Ros R, et al. Assaloni R, Giugliano D, Esposito K, Szabo C, Ceriello A. Intermittent high glucose enhances ICAM-1, VCAM-1, E-selectin and interleukin-6 expression in human umbilical endothelial cells in culture: the role of poly(ADP-ribose) polymerase. J Thromb Haemost 2004;2:1453-9.
13. Festa A, D'Agostino R Jr, Tracy RP, Haffner SM; Insulin Resistance Atherosclerosis Study. Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the insulin resistance atherosclerosis study. Diabetes 2002;51:1131-7.
14. Ceriello A. Impaired glucose tolerance and cardiovascular disease: the possible role of postprandial hyperglycemia. Am Heart J 2004;147: 803-7.